NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 428.20K | 255.50K | 367.30K | -19.70K | 109.40K |
| Total Depreciation and Amortization | 227.50K | 233.40K | 218.80K | -466.40K | 227.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | 691.90K | -- |
| Total Other Non-Cash Items | -11.20K | -11.50K | -9.00K | 316.50K | -33.90K |
| Change in Net Operating Assets | -5.00K | 274.40K | -331.50K | -350.30K | -210.50K |
| Cash from Operations | 639.50K | 751.80K | 245.70K | 172.00K | 92.10K |
| Capital Expenditure | -2.70K | -186.70K | -23.70K | -20.60K | -5.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.70K | -87.40K | -42.90K | -179.40K | -63.00K |
| Cash from Investing | -40.40K | -274.00K | -66.60K | -200.00K | -68.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -28.80K | -34.00K | -34.00K | -31.00K | -26.50K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 62.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -282.10K | -280.90K | -23.00K | -72.80K | -24.20K |
| Other Financing Activities | -- | -- | -- | 33.00K | -- |
| Cash from Financing | -303.10K | -305.40K | -46.70K | -71.40K | 2.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 296.10K | 172.40K | 132.40K | -99.30K | 25.70K |